Policy Steve Wosahla 10/30/24 Policy Steve Wosahla 10/30/24 Calling for an annual FDA report on the RACE for Children Act Read More Programs Jessica Kean 12/20/23 Programs Jessica Kean 12/20/23 A Look Back at 2023: What We've Achieved Together Read More Advocacy Steve Wosahla 2/24/23 Advocacy Steve Wosahla 2/24/23 International Pediatric Oncology Conference Highlights Role of Global Advocates Read More Policy Steve Wosahla 2/8/23 Policy Steve Wosahla 2/8/23 First Two Years of the RACE Act Evaluated in New GAO Report Read More Research Jessica Kean 4/19/21 Research Jessica Kean 4/19/21 Nausea, Taste, and Schedule Highlighted as Challenges in Survivor Focus Group on Medications Read More Research Jessica Kean 1/15/21 Research Jessica Kean 1/15/21 FDA Approves Crizotinib for Treatment of Rare Lymphoma in Children Read More Older Posts
Policy Steve Wosahla 10/30/24 Policy Steve Wosahla 10/30/24 Calling for an annual FDA report on the RACE for Children Act Read More
Programs Jessica Kean 12/20/23 Programs Jessica Kean 12/20/23 A Look Back at 2023: What We've Achieved Together Read More
Advocacy Steve Wosahla 2/24/23 Advocacy Steve Wosahla 2/24/23 International Pediatric Oncology Conference Highlights Role of Global Advocates Read More
Policy Steve Wosahla 2/8/23 Policy Steve Wosahla 2/8/23 First Two Years of the RACE Act Evaluated in New GAO Report Read More
Research Jessica Kean 4/19/21 Research Jessica Kean 4/19/21 Nausea, Taste, and Schedule Highlighted as Challenges in Survivor Focus Group on Medications Read More
Research Jessica Kean 1/15/21 Research Jessica Kean 1/15/21 FDA Approves Crizotinib for Treatment of Rare Lymphoma in Children Read More
